National Research Centre

Medical Research Ethics Committee

MREC Reviewer Comment

Protocol Title

Influence of Cu2O doped into calcium aluminate: structural, biocompatibility and antibacterial assessment.

Completely satisfied and informative data

Needs Explanation

Comments to the applicant

- Anticipated Start Date: You write 2024-08-04: Need to correct.

- Research Team Information: 3Co-Investigator: Sutrisnawati Mardin, Is from Indonesia. Do You obtained security agreement. 

- Sample size and groups: You write three groups. Need to explain.

- Safety Issues: Describe the method of disposal of residual human biospecimens: You write there is no human biospecimens. Need to correct, whereas you will use human normal fibroplast cell line (BJ1), that  will obtain from Vacsera.  

Comment to the Committee

- The protocol writes in the Reviewers distribution Table New submission. But the Applicant writes Re- submission.

- The protocol writes in my page Project. But it writes in the Reviewers distribution Table and the Applicant writes Search.

- Research Team Information: 3Co-Investigator: Sutrisnawati Mardin, Is from Indonesia. Does He obtain security agreement?

- The Applicant attaches the old Form of protocol (Paper) in the last attach file (Other Forms) under name: The-completed-consent-form-compressed-1.pdf  

Informed consent form:

Waiver

Login

Email Address *
Enter your username or email address
password *
Enter your password

Reset Password

User login/email

Still not a member? Register